Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 30 Nov 2022 – 20 Aug 2026, limited by HDFC Business Cycle Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HDFC Business Cycle Fund | Nifty 500 |
|---|---|---|
| 30 Nov 2022 | ₹100.00 | ₹100.00 |
| 23 Mar 2023 | ₹94.83 | ₹90.33 |
| 15 Jul 2023 | ₹110.02 | ₹105.14 |
| 05 Nov 2023 | ₹111.78 | ₹106.61 |
| 26 Feb 2024 | ₹128.52 | ₹127.03 |
| 18 Jun 2024 | ₹140.27 | ₹140.03 |
| 10 Oct 2024 | ₹149.58 | ₹147.99 |
| 31 Jan 2025 | ₹136.99 | ₹135.34 |
| 24 May 2025 | ₹141.39 | ₹142.86 |
| 14 Sep 2025 | ₹149.22 | ₹145.43 |
| 06 Jan 2026 | ₹148.65 | ₹150.57 |
| 29 Apr 2026 | ₹141.54 | ₹143.43 |
| 20 Aug 2026 | ₹153.76 | ₹147.45 |
| Metric | HDFC · Regular NAV ₹15.39 Very High risk ★★☆☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +2.47% | +5.83% | |
| +11.83% | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +12.26% | +12.26% | |
| +9.88% | — | |
| +12.17% | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 13.82% | 15.62% | |
| 0.39 | 0.43 | |
| 0.53 | 0.59 | |
| -19.40% | -23.65% | |
| Nifty 500 | — | |
| +0.22% | +3.42% | |
| 0.94 | 0.95 | |
| 94.2% | 105.9% | |
| 90.6% | 93.6% | |
| 2.14% | 2.39% | |
| ₹2,594Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹102 | — | |
| 45% | 45% | |
| Dhruv Muchhal | — | |
| 30 Nov 2022 | — | |
| 60 | — | |
| 42.6% | — | |
| 1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.